Sunday, April 27, 2025 12:48:36 PM
x,
Thanks for your keen insights about combos 😶
For DCVax-L, there are two combo trials that are particularly relevant today:
⭐️You will be pleased to notice placebo-controlled RCTs on the list!⭐️
☑️ Completed Hiltonol (poly-ICLC) Trial:
https://clinicaltrials.gov/study/NCT01204684
☑️ Ongoing Hiltonol (poly-ICLC) Trial:
https://www.clinicaltrials.gov/study/NCT04201873
The research at Roswell was recently approved to expand … Two of their DC combo trials are particularly noteworthy—active, grant-funded, and posted recent updates!
☑️ https://clinicaltrials.gov/study/NCT04348747?a=29&b=30
☑️ https://clinicaltrials.gov/study/NCT04093323
There are other P1 or P2 studies too at Moffitt that seem to overlap with Roswell, and Moffitt has a couple additional studies that will soon be recruiting… We may soon hear more about Roswell’s collaboration with Moffitt which could be very significant news, imo.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176090178
Among the listed Moffitt dendritic cell trials (that are active now), Roswell is included/mentioned! One study involves an interesting DC combo with adoptive T Cell therapy! All four trials appear to be active with recently posted updates on clinicaltrials.gov:
https://clinicaltrials.gov/study/NCT05325632
https://clinicaltrials.gov/study/NCT04348747
(Roswell trial listed on Moffitt website and has Moffitt in Florida as one of the study locations)
https://clinicaltrials.gov/study/NCT05809752
(Moffitt trial with planned study location at Roswell)
https://clinicaltrials.gov/study/NCT05378464
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176090178
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175935295
“They called me Gabagool Research”
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176114523
Thanks for your keen insights about combos 😶
For DCVax-L, there are two combo trials that are particularly relevant today:
⭐️You will be pleased to notice placebo-controlled RCTs on the list!⭐️
☑️ Completed Hiltonol (poly-ICLC) Trial:
https://clinicaltrials.gov/study/NCT01204684
☑️ Ongoing Hiltonol (poly-ICLC) Trial:
https://www.clinicaltrials.gov/study/NCT04201873
The research at Roswell was recently approved to expand … Two of their DC combo trials are particularly noteworthy—active, grant-funded, and posted recent updates!
☑️ https://clinicaltrials.gov/study/NCT04348747?a=29&b=30
☑️ https://clinicaltrials.gov/study/NCT04093323
There are other P1 or P2 studies too at Moffitt that seem to overlap with Roswell, and Moffitt has a couple additional studies that will soon be recruiting… We may soon hear more about Roswell’s collaboration with Moffitt which could be very significant news, imo.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176090178
Among the listed Moffitt dendritic cell trials (that are active now), Roswell is included/mentioned! One study involves an interesting DC combo with adoptive T Cell therapy! All four trials appear to be active with recently posted updates on clinicaltrials.gov:
https://clinicaltrials.gov/study/NCT05325632
https://clinicaltrials.gov/study/NCT04348747
(Roswell trial listed on Moffitt website and has Moffitt in Florida as one of the study locations)
https://clinicaltrials.gov/study/NCT05809752
(Moffitt trial with planned study location at Roswell)
https://clinicaltrials.gov/study/NCT05378464
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176090178
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175935295
“They called me Gabagool Research”
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176114523
Bullish
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
